In vitro pharmacokinetics/pharmacodynamics of FL058 (a novel beta-lactamase inhibitor) combined with meropenem against carbapenemase-producing Enterobacterales

In vitro pharmacokinetics/pharmacodynamics of FL058 (a novel beta-lactamase inhibitor) combined with meropenem against carbapenemase-producing Enterobacterales

Objective: FL058 is a novel beta-lactamase inhibitor with a broad spectrum of activity and a favorable safety profile. The objective of this study was to evaluate pharmacokinetic/pharmacodynamic (PK/PD) relationships for the combination of FL058 and meropenem in an in vitro infection model.Methods:...

Full description

Bibliographic Details
Main Authors: Zhiwei Huang, Xingchen Bian, Yi Li, Jiali Hu, Beining Guo, Xinyi Yang, Yi Jin, Shansong Zheng, Xinmei Wang, Cong Gao, Jing Zhang, Xiaojie Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-04-01
Series:Frontiers in Pharmacology
Subjects:
beta-lactamase inhibitor
meropenem
in vitro model
pharmacokinetics/pharmacodynamics
carbapenemase-producing Enterobacterales
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1282480/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2024.1282480/full

Similar Items